“It's like rolling the dice for what you get in your vial. Both the FDA and EMA knew this but kept this out of the public view because if it were known, nobody would take the vaccines.”

Note: I could not get the video to play in the Brave browser but it played fine in Firefox.

“Pfizer and Moderna are making about $50 billion a year on these shots and they want that to continue. So they need to reformulate. Maybe target a new variant, maybe change some of the ingredients — who knows, these shots have disappointed so it’s not clear what it will take to get them to work. This is a problem because reformulated shots mean new clinical trials and new regulatory reviews by the FDA. There is a decent chance that any reformulated shot might fail a new clinical trial, and the public is deeply skeptical of these shots already, so the scrutiny would be intense.”

“As most of my regular readers know, the topic of reinfections in vaccinated people was something I was interested in since the Fall of 2021. This issue is hugely important since if people can catch Covid more than once, this pandemic has the potential to never end.”

“Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid - its COVID-19 antiviral pill - for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree.”

““If you take Paxlovid, you might get symptoms again,” Walensky told CBS News on Tuesday.”

“There is no approved treatment for Long COVID (aka Long Haulers) and there are very few clinical trials for the debilitating condition, but Pfizer (PFE) and Todos Medical (TOMDF) might have stumbled onto a solution that could not only help the sufferers but also help pull the United States economy out of the current downturn.”

We think this is interesting on several levels.

“What made Pfizer change this criterion? My speculative answer is that Pfizer knew that Paxlovid did not work in the vaccinated. Having failed to hit the target when it came to vaccinated people, Pfizer decided to remove them from the trial and “move the target,” so to speak. This way, the EPIC-SR study would end up being a “success,” technically.”

“The FDA has asked a federal judge to make the public wait until the year 2076 to disclose all of the data and information it relied upon to license Pfizer’s COVID-19 vaccine.”

The question of the day is what don't they want us to see?

All through this pandemic, Big Pharma has been letting Big Tech, Big Government, and Big Media carry their water on fact-checking and censorship.  So What Changed?

“On Tuesday, October 26, 2021, the FDA is meeting “to discuss a request to amend Pfizer-BioNTech’s Emergency Use Authorization (EUA) for the administration of their COVID-19 mRNA vaccine to children 5 through 11 years of age.””

Great Question, Sundance.